Knight Therapeutics
Arvind Utchanah, CPA CA has extensive work experience in finance and accounting, with a focus on the pharmaceutical industry. Arvind began their career at EY in 2007, where they worked as a Manager in Assurance services until 2012. Arvind then joined Paladin Labs and held various positions including Financial Analyst, Finance Manager, Associate Director of Finance, and Director of Finance, Accounting and Financial Planning & Analysis. In 2016, Utchanah joined Knight Therapeutics as Director of Finance, and later took on the roles of VP of Finance and Chief Financial Officer.
Arvind Utchanah, CPA CA, obtained a Diploma in Chartered Accountancy from Concordia University between 2007 and 2009. Prior to that, they earned a Bachelor of Commerce (BCom) in Accounting from McGill University from 2004 to 2007.
This person is not in any offices
Knight Therapeutics
1 followers
Knight Therapeutics Inc. is a pan-American (ex-US) specialty pharmaceutical company focused on acquiring, in licensing, out-licensing, marketing, and commercializing innovative prescription pharmaceuticals in Canada and Latin America. Headquartered in Montreal, Knight has operations in Canada and in 10 countries in Latin America and has over 700 employees globally. Knight Therapeutics Inc.’s shares trade on TSX under the symbol GUD.